APM
Avidity Partners Management Portfolio holdings
AUM
$499M
This Quarter Return
+16.93%
1 Year Return
+3.47%
3 Year Return
+181.12%
5 Year Return
+409%
10 Year Return
–
AUM
$4.6B
AUM Growth
+$4.6B
(+5.5%)
Cap. Flow
+$336M
Cap. Flow
% of AUM
7.3%
Top 10 Holdings %
Top 10 Hldgs %
38.55%
Holding
111
New
28
Increased
28
Reduced
21
Closed
14
Top Buys
| 1 |
Eli Lilly
LLY
|
$128M |
| 2 |
Prothena Corp
PRTA
|
$119M |
| 3 |
Akero Therapeutics
AKRO
|
$106M |
| 4 |
Sarepta Therapeutics
SRPT
|
$105M |
| 5 |
Axsome Therapeutics
AXSM
|
$68.7M |
Top Sells
| 1 |
AstraZeneca
AZN
|
$161M |
| 2 |
Johnson & Johnson
JNJ
|
$160M |
| 3 |
McKesson
MCK
|
$127M |
| 4 |
UnitedHealth
UNH
|
$124M |
| 5 |
AbbVie
ABBV
|
$116M |
Sector Composition
| 1 | Healthcare | 96.68% |
| 2 | Financials | 0.52% |
| 3 | Technology | 0% |
